Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Clin Pharmacol Ther. 2018 Oct 9;105(3):692–702. doi: 10.1002/cpt.1220

Table 4.

Final model parametersa for the exposure-response of disulfiram on cell-associated unspliced (CA-US) HIV-1 RNA.

Pharmacodynamic Parameters Estimate (RSE, %a)
λbase (copies/106 CD4+ T cells) 103 (13.6)
OVDP 0.282 (6.1)
AUC50 (mg*h/L) 1600 (8.9)
Emax (fraction increase) 78 (13.6)
Gamma 15.3 (11.5)
BSV (Baseline) (CV %) 154 (16.2)
BSV (Overdispersion) (CV %) 54 (24.0)
BSV (AUC50) (CV %) 38 (87.7)
BSV (Emax) (CV %) 47 (49.4)

Abbreviations: λBase = mean baseline count of HIV-1 RNA, OVDP= overdispersion parameter describing the negative binomial function, AUC = area under the curve; DSF = disulfiram; Emax = concentration at which maximum efficacy observed; Gamma = parameter to account for shape; BSV = between-subject variability); CV = coefficient of variation.

a

Obtained by nonparametric bootstrap with 100 samples.